WNT3A and Parkinson disease: This study investigated the protective effects of Wnt3a-conditioned medium on a cellular model of PD and showed that Wnt/β-catenin pathway was inhibited after treatment of 100 μM 6-OHDA for 24 h, evidenced by the decreased β-catenin level and increased GSK3β activity.